---
title: "CPHI – Frankfurt"
id: "1686"
type: "post"
slug: "cphi-frankfurt"
published_at: "2025-09-05T06:50:59+00:00"
modified_at: "2025-09-16T11:56:01+00:00"
url: "https://innocorepharma.com/news-events/cphi-frankfurt/"
markdown_url: "https://innocorepharma.com/news-events/cphi-frankfurt.md"
taxonomy_category:
  - "Events"
---

Frankfurt, 29 & 30 October

# CPHI – Frankfurt

# **InnoCore Pharmaceuticals Attends the CPHI Frankfurt – Discover Advanced Long-Acting Injectable Technologies**

InnoCore Pharmaceuticals is excited to join the CPHI in Frankfurt, one of the world’s leading pharmaceutical networking events. Join us to explore how our SynBiosys® platform is transforming the development of biodegradable long-acting injectables for peptides, proteins, and other biologics.

## Reducing dosing frequencies

[Vincent de Boer](https://innocorepharma.com/company/people/vincent-de-boer/)
, Business Development Manager, will be available to discuss:

- Our bespoke tailored sustained-release formulations
- How we overcome the PLGA limitations such as aggregation, acylation, and high local pH
- How we achieve sustained release profiles from one week to several months
- Collaborative development from early-stage R&D to clinical supply

### Meet at the CPHI!

Connect with Vincent to learn more about our innovative drug delivery solutions and explore partnership opportunities.

Whether you’re looking to extend dosing intervals, improve patient compliance, or transition from IV to subcutaneous delivery, InnoCore offers proven expertise and tailored solutions to meet your formulation needs.

**Let’s connect at CPHI Frankfurt and shape the future of injectable therapeutics together.**

"*" indicates required fields

Related insights

[26 July 2018 | Funding InnoCore and Merck enter global collaboration Merck and InnoCore Pharmaceuticals to Improve Patient Compliance with New Drug Delivery Technology. Read the full story](https://innocorepharma.com/news-events/innocore-and-merck-enter-global-collaboration/)
[11 September 2020 | Funding Bill & Melinda Gates Foundation Grant Awarded InnoCore Pharmaceuticals has been awarded a grant by the Bill & Melinda Gates Foundation to develop a long-acting injectable contraceptive implant. Read the full story](https://innocorepharma.com/news-events/innocore-awarded-grant-by-the-bill-melinda-gates-foundation-in-contraception/)
[01 January 2021 | Funding InnoCore leads Consortium in Influenza vaccines InnoCore Pharmaceuticals has secured funding from the European Regional Development Fund to develop a biodegradable polymer-based microneedle array patch. Read the full story](https://innocorepharma.com/news-events/innocore-leads-consortium-in-influenza-vaccines/)